Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Cerevel Therapeutics
company
About
Cerevel Therapeutics is a biopharmaceutical company.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $320M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Oct 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson’s disease and substance use disorder.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$320M
Cerevel Therapeutics has raised a total of
$320M
in funding over 2 rounds. Their latest funding was raised on
Jul 29, 2020 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 29, 2020 | Post-IPO Equity | $320M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Cerevel Therapeutics is funded by 1 investors.
Pfizer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pfizer
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
